Skip to content
Friday 17 July 2026EN · DE
City PM

European business, markets and politics

  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Friday 24 November 2023 4:38 pm

Biotech to breast pumps: Meet the UK’s five fastest growing female founded firms

By: Jessica Frank-Keyes

Political Reporter

Add as a preferred source on Google
After selling his voice assistant startup to Amazon in 2012, William Tunstall-Pedoe helped create Alexa, and is now launching Unlikely AI.
After selling his voice assistant startup to Amazon in 2012, William Tunstall-Pedoe helped create Alexa, and is now launching Unlikely AI.

Biotech, climate finance and robotics are among the top five fastest-growing female-founded firms in the UK, a study has found.

Loop Technology, an automation company, NovaBiotics, which develops drugs for rare diseases, and Opna, which finances net zero projects, all took a slot in the top five.

Breast pump firm Elvie and sustainable menstrual company Mooncup made up the remainder of the group, according to the study by SpareMyTime, a virtual assistant platform.

Melissa Gauge, SpareMyTime founder, said the firm’s success was a “testament to the growing strength of UK tech and the increasing importance of diversity and inclusion”.

She added: “We are particularly excited to see so many companies focused on solving real-world problems, which means UK female founders are committed to making a positive impact in the world.”

It follows the Alan Turing Institute last month unveiling gender inequality in artificial intelligence (AI) funding, with female-founded firms just two per cent of start-up deals since 2014, and raising just £1.3m on average per deal compared to £8.6m for all-male teams.

The SpareMyTime study put London-based Elvie, founded by Tania Boler, in the top spot, with £124m in total funding over the firm’s lifetime, while Samantha Reece’s Dorset-located Loop Technology — which is creating an artificial pancreas for people with diabetes — was second with £12.7m.

Read more

Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

Hikma produces generic drugs

Aberdeen’s NovaBiotics, led by Deborah O’Neil, which is developing new antibiotics to combat drug-resistant bacteria, came in third with £10.9m, and Su Hardy’s Mooncup, from the Wirral, was close behind with £10m.

And Shilpika Gautam’s climate fintech Opna, also based in London, ranked fifth with £5.2m.

It comes as the study also revealed the number of female CEOs and women on boards across the whole of the UK’s FTSE has increased by 83 per cent since 2018.

While London is leading the way with the highest number — 174 — of female founders, followed by Scotland with 43, and Yorkshire and the Humber with 39.

Completing the top five were the South East with 23 and Greater Manchester with 20.

However, when it comes to funding, female entrepreneurs still only secure a small fraction compared to male founders.

The European Investment Bank (EIB) found that in 2021 women received just one per cent of venture capital investment, while in the US, the figure was just two per cent that year, the smallest share in half a decade.

Read more

Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Investing
  • Business

Trending Articles

  • James Watt offers to buy back Brewdog

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • Motsepe backed to succeed Fifa’s Infantino by South African minister

  • Brewdog owner shrugs off James Watt takeover bid

  • Finsbury lines up Games Workshop splurge using merger windfall

More from City PM

  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Nothing fails to file accounts months after dissolution threat

    Tech
    Nothing Phone 1 showcasing its transparent back design and unique LED light interface, representing innovation in smartpho...
  • Fifa World Cup had amazing stadiums, 2035 UK edition must too

    Sport Business
    Breaking news concept with digital newspaper on tablet and financial graph overlay, symbolizing current events and market ...
  • Legado and Amiqus Partner to Streamline Regulated Onboarding in UK Financial Services Sector

    Business Wire
  • Exclusive: Eilish McColgan joins performance nutrition brand Science in Sport

    Sport Business
    SIS EM 013 showcasing dynamic business environment with professionals engaging in strategic discussions at a conference table
  • Revolut price tag ‘just a stepping stone’ to a trillion, says Fuse boss

    Fintech
    Revolut office interior showcasing modern workspace design with collaborative areas and tech-savvy workstations
  • Global Millionaire Population Jumps by Nearly 2 Million in 2025, Driven by Strong Stock Market Performance Worldwide

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook